[Use of a new oral anticholinergic agent in acute pancreatitis].
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001285:Atropine / Q000009:adverse effects; D002764:Cholecystitis / Q000188:drug therapy; D002769:Cholelithiasis / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000188:drug therapy*; D010276:Parasympatholytics / Q000008:administration & dosage* / Q000009:adverse effects; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage; D014268:Trifluoperazine / Q000008:administration & dosage*
D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D014268:Trifluoperazine; D001285:Atropine
Uber die Verwendung eines neuen peroralen Anticholinergikum bei der akuten Pankreatitis.